James Parsons's most recent trade in DiaMedica Therapeutics Inc was a trade of 51,189 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 51,189 | 51,189 | - | - | Stock Option (right to buy) | |
| Oncolytics Biotech Inc | James T. Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option | |
| City Holding Co. | James M. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 121.60 per share. | 12 May 2026 | 100 | 2,800 (0%) | 0% | 121.6 | 12,160 | Common Stock |
| Oncolytics Biotech Inc | James T. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 1.03 per share. | 11 Mar 2026 | 10,000 | 41,849 (0%) | 0% | 1.0 | 10,300 | Common Shares |
| City Holding Co. | James M. Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2026 | 265 | 531 (0%) | 0% | 0 | Common Stock | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 8.42 per share. | 02 Jan 2026 | 10,095 | 97,949 (0%) | 0% | 8.4 | 85,000 | Common Stock |
| DiaMedica Therapeutics Inc | James Parsons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2025 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.20 per share. | 21 Nov 2025 | 12,000 | 87,854 (0%) | 0% | 2.2 | 26,400 | Common Stock |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2025 | 40,739 | 40,739 | - | - | Stock Option (right to buy) | |
| City Holding Co. | James M. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 122.38 per share. | 12 May 2025 | 2,200 | 2,700 (0%) | 0% | 122.4 | 269,225 | Common Stock |
| City Holding Co. | James M. Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2025 | 266 | 266 (0%) | 0% | 0 | Common Stock | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 5.34 per share. | 02 Jan 2025 | 15,917 | 75,854 (0%) | 0% | 5.3 | 84,997 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 4,287 | 4,287 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2024 | 28,472 | 28,472 | - | - | Stock Option (right to buy) | |
| City Holding Co. | James M. Parsons | Director | Purchase of securities on an exchange or from another person at price $ 102.10 per share. | 30 May 2024 | 400 | 500 (0%) | 0% | 102.1 | 40,842 | Common Stock |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 2.80 per share. | 02 Jan 2024 | 21,428 | 59,937 (0%) | 0% | 2.8 | 59,998 | Voting Common Shares, no par value per share |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 16,968 | 16,968 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
| DiaMedica Therapeutics Inc | James Parsons | Director | Grant, award, or other acquisition of securities at price $ 3.58 per share. | 03 Jan 2022 | 16,773 | 38,509 (0%) | 0% | 3.6 | 60,047 | Voting Common Shares, no par value per share |